Related references
Note: Only part of the references are listed.Urate as a Marker of Risk and Progression of Neurodegenerative Disease
Sabrina Paganoni et al.
NEUROTHERAPEUTICS (2017)
Metabolomics in Alzheimer's disease: The need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology
Raul Gonzalez-Dominguez et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia
Jesper F. Havelund et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Distinct Metabolomic Signature in Cerebrospinal Fluid in Early Parkinson's Disease
Jean-Pierre Trezzi et al.
MOVEMENT DISORDERS (2017)
Metabolic Profiling of Parkinson's Disease and Mild Cognitive Impairment
Florence Burte et al.
MOVEMENT DISORDERS (2017)
N370S-GBA1 Mutation Causes Lysosomal Cholesterol Accumulation in Parkinson's Disease
Patricia Garcia-Sanz et al.
MOVEMENT DISORDERS (2017)
Metabolomic biomarkers as strong correlates of Parkinson disease progression
Peter A. LeWitt et al.
NEUROLOGY (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease
Shinji Saiki et al.
SCIENTIFIC REPORTS (2017)
Microbiota and neurodegenerative diseases
Moira Marizzoni et al.
CURRENT OPINION IN NEUROLOGY (2017)
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis?
Madelyn C. Houser et al.
NPJ PARKINSONS DISEASE (2017)
Identification of novel biomarkers for Parkinson's disease by metabolomic technologies
Taku Hatano et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
N, N-Dimethylglycine decreases oxidative stress and improves in vitro development of bovine embryos
Toshikiyo Takahashi et al.
JOURNAL OF REPRODUCTION AND DEVELOPMENT (2016)
Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects
Anna Wuolikainen et al.
MOLECULAR BIOSYSTEMS (2016)
L-DOPA Reverses the Increased Free Amino Acids Tissue Levels Induced by Dopamine Depletion and Rises GABA and Tyrosine in the Striatum
Oscar Solis et al.
NEUROTOXICITY RESEARCH (2016)
Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis
Medi Kori et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2016)
MetFrag relaunched: incorporating strategies beyond in silico fragmentation
Christoph Ruttkies et al.
JOURNAL OF CHEMINFORMATICS (2016)
Metallomic Biomarkers in Cerebrospinal fluid and Serum in patients with Parkinson's disease in Indian population
Jaya Sanyal et al.
SCIENTIFIC REPORTS (2016)
IPO: a tool for automated optimization of XCMS parameters
Gunnar Libiseller et al.
BMC BIOINFORMATICS (2015)
Optimized Analytical Procedures for the Untargeted Metabolomic Profiling of Human Urine and Plasma by Combining Hydrophilic Interaction (HILIC) and Reverse-Phase Liquid Chromatography (RPLC)-Mass Spectrometry
Kevin Contrepois et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis
Jennifer T. Lamberts et al.
NEUROBIOLOGY OF DISEASE (2015)
NMR metabonomics of cerebrospinal fluid distinguishes between Parkinson's disease and controls
Anders Ohman et al.
NEUROSCIENCE LETTERS (2015)
MetaboAnalyst 3.0-making metabolomics more meaningful
Jianguo Xia et al.
NUCLEIC ACIDS RESEARCH (2015)
Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation
Maja Jazvinscak Jembrek et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Searching molecular structure databases with tandem mass spectra using CSI:FingerID
Kai Duehrkop et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Oxidative stress and Parkinson's disease
Javier Blesa et al.
FRONTIERS IN NEUROANATOMY (2015)
Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease
Hemi Luan et al.
SCIENTIFIC REPORTS (2015)
The central biobank and virtual biobank of BiOMarKaPD: a resource for studies on neurodegenerative diseases
Babette L. R. Reijs et al.
FRONTIERS IN NEUROLOGY (2015)
Neuroinflammation in Parkinson's disease and its potential as therapeutic target
Qinqin Wang et al.
TRANSLATIONAL NEURODEGENERATION (2015)
LC MS-Based Urinary Metabolite Signatures in Idiopathic Parkinson's Disease
Hemi Luan et al.
JOURNAL OF PROTEOME RESEARCH (2015)
The significance of GBA for Parkinson's disease
Kathrin Brockmann et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2014)
Plasma phospholipids identify antecedent memory impairment in older adults
Mark Mapstone et al.
NATURE MEDICINE (2014)
Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease
Michelle M. Mielke et al.
NEUROBIOLOGY OF AGING (2014)
CFM-ID: a web server for annotation, spectrum prediction and metabolite identification from tandem mass spectra
Felicity Allen et al.
NUCLEIC ACIDS RESEARCH (2014)
The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis
Eveliina Pollari et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network
Mustafa Sertbas et al.
FEBS OPEN BIO (2014)
Upstream deregulation of calcium signaling in Parkinson's disease
Pilar Rivero-Rios et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
Direct infusion mass spectrometry metabolomics dataset: a benchmark for data processing and quality control
Jennifer A. Kirwan et al.
SCIENTIFIC DATA (2014)
Metabolite and Peptide Levels in Plasma and CSF Differentiating Healthy Controls from Patients with Newly Diagnosed Parkinson's Disease
Miles Trupp et al.
JOURNAL OF PARKINSONS DISEASE (2014)
Biomarkers of Parkinson's disease: current status and future perspectives
Jian Wang et al.
DRUG DISCOVERY TODAY (2013)
Microbial-Mammalian Cometabolites Dominate the Age-associated Urinary Metabolic Phenotype in Taiwanese and American Populations
Jonathan R. Swann et al.
JOURNAL OF PROTEOME RESEARCH (2013)
3-Hydroxykynurenine and Other Parkinson's Disease Biomarkers Discovered by Metabolomic Analysis
Peter A. LeWitt et al.
MOVEMENT DISORDERS (2013)
Global metabolic profiling of animal and human tissues via UPLC-MS
Elizabeth J. Want et al.
NATURE PROTOCOLS (2013)
Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study
Michelle M. Mielke et al.
PLOS ONE (2013)
Serum Metabolomics of Slow vs. Rapid Motor Progression Parkinson's Disease: a Pilot Study
James R. Roede et al.
PLOS ONE (2013)
Role of Oxidative Stress in Parkinson's Disease
Onyou Hwang
Experimental Neurobiology (2013)
The Role of Oxidative Stress in Parkinson's Disease
Vera Dias et al.
JOURNAL OF PARKINSONS DISEASE (2013)
IDEOM: an Excel interface for analysis of LC-MS-based metabolomics data
Darren J. Creek et al.
BIOINFORMATICS (2012)
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics
Manfred Gerlach et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
LC-MS-based metabolomics
Bin Zhou et al.
MOLECULAR BIOSYSTEMS (2012)
Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin
Gary J. Patti et al.
NATURE CHEMICAL BIOLOGY (2012)
Progression of motor symptoms in Parkinson's disease
Ruiping Xia et al.
NEUROSCIENCE BULLETIN (2012)
Lipidomics of Alzheimer's disease: current status
Paul L. Wood
ALZHEIMERS RESEARCH & THERAPY (2012)
PeakML/mzMatch: A File Format, Java Library, R Library, and Tool-Chain for Mass Spectrometry Data Analysis
Richard A. Scheltema et al.
ANALYTICAL CHEMISTRY (2011)
Toward Global Metabolomics Analysis with Hydrophilic Interaction Liquid Chromatography-Mass Spectrometry: Improved Metabolite Identification by Retention Time Prediction
Darren J. Creek et al.
ANALYTICAL CHEMISTRY (2011)
Reduced but Not Oxidized Cerebrospinal Fluid Glutathione Levels are Lowered in Lewy Body Diseases
Walter Maetzler et al.
MOVEMENT DISORDERS (2011)
Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis
S. Cipriani et al.
BIOMARKERS IN MEDICINE (2010)
Tau protein: Relevance to Parkinson's disease
Peng Lei et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Mitochondrial dysfunction: A potential link between neuroinflammation and neurodegeneration?
Maarten E. Witte et al.
MITOCHONDRION (2010)
Deregulated Sphingolipid Metabolism and Membrane Organization in Neurodegenerative Disorders
Marco Piccinini et al.
MOLECULAR NEUROBIOLOGY (2010)
Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting
Karsten Suhre et al.
PLOS ONE (2010)
Acylcarnitines: Role in brain
Lauren L. Jones et al.
PROGRESS IN LIPID RESEARCH (2010)
Compensation for Systematic Cross-Contribution Improves Normalization of Mass Spectrometry Based Metabolomics Data
Henning Redestig et al.
ANALYTICAL CHEMISTRY (2009)
Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
Alberto Ascherio et al.
ARCHIVES OF NEUROLOGY (2009)
Serum uric acid levels in patients with Parkinson's disease: Their relationship to treatment and disease duration
Elisabeth Andreadou et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2009)
Current strategies in the treatment of Parkinson's disease and a personalized approach to management
Nancy L. Diaz et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Metabolomic Profiling in LRRK2-Related Parkinson's Disease
Krisztina K. Johansen et al.
PLOS ONE (2009)
Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection
Shiek S. S. J. Ahmed et al.
JOURNAL OF BIOMEDICAL SCIENCE (2009)
Metabolomic profiling to develop blood biomarkers for Parkinson's disease
Mikhail Bogdanov et al.
BRAIN (2008)
A review of Parkinson's disease
C. A. Davie
BRITISH MEDICAL BULLETIN (2008)
Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease
Jose Bras et al.
FEBS JOURNAL (2008)
Building Predictive Models in R Using the caret Package
Max Kuhn
JOURNAL OF STATISTICAL SOFTWARE (2008)
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Anthony H. V. Schapira
LANCET NEUROLOGY (2008)
Membrane lipids: where they are and how they behave
Gerrit van Meer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Imaging amyloid deposition in Lewy body diseases
S. N. Gomperts et al.
NEUROLOGY (2008)
Metabolomic analysis of urine and serum in Parkinson's disease
Andrew W. Michell et al.
METABOLOMICS (2008)
Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide
Akhlaq A. Farooqui et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Normalization method for metabolomics data using optimal selection of multiple internal standards
Marko Sysi-Aho et al.
BMC BIOINFORMATICS (2007)
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
E. R. Dorsey et al.
NEUROLOGY (2007)
The onset of brain injury and neurodegeneration triggers the synthesis of docosanoid neuroprotective signaling
Nicolas G. Bazan
CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)
XCMS: Processing mass spectrometry data for metabolite profiling using Nonlinear peak alignment, matching, and identification
CA Smith et al.
ANALYTICAL CHEMISTRY (2006)
Inhibitors of brain phospholipase A(2) activity: Their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders
Akhlaq A. Farooqui et al.
PHARMACOLOGICAL REVIEWS (2006)
ROBPCA: A new approach to robust principal component analysis
M Hubert et al.
TECHNOMETRICS (2005)
Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism
K Hanada
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2003)
A Bayesian missing value estimation method for gene expression profile data
S Oba et al.
BIOINFORMATICS (2003)
Hierarchical organization of modularity in metabolic networks
E Ravasz et al.
SCIENCE (2002)
The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease
ML Selley et al.
NEUROBIOLOGY OF AGING (2002)
Sphingomyelin and ceramide as regulators of development and lifespan
RG Cutler et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2001)
Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders
AA Farooqui et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2000)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
